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Introduction
The ability of most cells to survive, proliferate and migrate
is regulated in part by the adhesive interactions they make
with different components of the surrounding extracellular
matrix (ECM), such as fibronectin (FN) (Boudreau and Jones,
1999). Attachment to FN is mediated through two different
types of adhesion receptors, integrins and syndecans (Bass
and Humphries, 2002; Hynes, 2002). Integrins are
transmembrane heterodimers comprising  and  subunits.
Different  combinations show specificity for different
ECM ligands, with v3 and 51 being some of the major
integrin receptors that bind to FN (Hynes, 2002). Syndecans
are transmembrane heparan sulfate proteoglycans,
characterized by the presence of long glycosaminoglycan
chains attached to the extracellular domain of the proteins.
Specifically, syndecan-4 has been implicated in signaling
processes downstream of adhesion to FN (Bass and
Humphries, 2002; Bass et al., 2007).
The mature FN molecule is a dimer of two disulfide-linked
chains. Each monomer chain contains multiple repeat domains,
and distinct regions serve as binding sites for the different
adhesion receptors. The tripeptide RGD sequence in FN repeat
III10, part of the cell-binding domain (CBD), is the central
recognition sequence required for most FN-binding integrins
(Hynes, 2002; Pankov and Yamada, 2002). A different region
containing FN repeats III12-14 is the major heparin-binding
domain (HBD) and serves as the attachment site for syndecans
(Bass and Humphries, 2002).
Attachment of cells to FN activates different members of the
Rho family of small GTPases, allowing cells to spread and
migrate efficiently by means of dynamic rearrangements of the
actin cytoskeleton. Formation of filopodia, lamellipodia and
small focal complexes, controlled by Cdc42 and Rac1, allows
cells to attach to and spread on the matrix. Activation of RhoA
causes the formation of stress fibers and focal adhesions, which
tends to counter spreading and results in stable adhesion to the
matrix (Burridge and Wennerberg, 2004; Defilippi et al., 1999;
Nobes and Hall, 1995). Although it is clear that RhoA is
activated downstream of adhesion to FN, the specific
contributions of integrins and/or syndecans to this increase in
activity remains more controversial (Saoncella et al., 1999;
Wang et al., 2005).
Rho proteins are activated when they bind to GTP and
inactivated when the nucleotide is hydrolyzed to GDP. This
regulatory cycle is controlled by different protein families.
GTPase-activating proteins (GAPs) decrease Rho protein
activity by stimulating their intrinsic GTP hydrolysis activity
(Moon and Zheng, 2003). Guanine nucleotide exchange factors
(GEFs) increase the activity of Rho proteins by promoting the
exchange of GDP for GTP. Specifically, GEFs for Rho proteins
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perform this function by binding to the GTPase and
destabilizing the nucleotide-binding pocket, allowing for
dissociation of the bound GDP. Owing to the high GTP:GDP
ratio in the cytoplasm, the lost GDP is quickly replaced by GTP
(Rossman et al., 2005).
The Dbl family of proteins is a large group of exchange
factors for the Rho GTPases, which are characterized by
tandem Dbl homology (DH) and pleckstrin-homology (PH)
domains. DH domains are responsible for the catalytic activity
of the proteins. Functions for the PH domain range from
assisting in the exchange reaction to membrane anchorage or
protein binding (Rossman et al., 2005). Of the approximately
70 known members of the Dbl GEF family, very few have been
extensively studied. Little is known about which specific GEFs
are responsible for linking different ECM signals (such as
adhesion to FN) to Rho proteins. Considering the major
regulatory function of GEFs in controlling the function of Rho
proteins, this represents a major gap in our understanding of
this signaling pathway. Several lines of evidence have indicated
that activation of Rac by ECM adhesion occurs through the
Dock180-ELMO complex. Dock180 is a member of a second
family of unconventional GEFs that lack DH domains (Meller
et al., 2005). The exchange factor Vav1 might also be
responsible for transmitting ECM signals to Rac, but such a
role for Vav1 is restricted mainly to cells of the hemopoietic
lineage (Hornstein et al., 2004).
The major goal of this project was to identify the GEF(s)
responsible for FN-induced RhoA activation. Using a
nucleotide-free mutant of RhoA (which has a high affinity
for activated GEFs), we identified Lsc/p115 RhoGEF and
leukemia-associated RhoGEF (LARG) as candidate GEFs for
activation of RhoA downstream of FN. Lsc (the murine
homolog of p115 RhoGEF) belongs to a family of RhoA-
specific GEFs known as RGS-GEFs, which also includes
PDZ-RhoGEF. The RGS-GEFs have been best characterized
as exchange factors responsible for RhoA activation by
stimulation of G-protein-coupled receptors (GPCRs)
(Fukuhara et al., 2001). However, in this study, we demonstrate
that Lsc/p115 RhoGEF and LARG also play an important role
in the activation of RhoA downstream of FN.
Results
The RhoA GEFs Lsc/p115 RhoGEF and LARG are
activated upon adhesion of fibroblasts to FN
The spreading of cells on FN is a dynamic process. When
suspended REF52 fibroblasts are re-plated onto FN,
coordinated control of cytoskeletal remodeling by several
members of the Rho family of GTPases causes the cell
morphology to change from round to flattened, with extensive
adhesions to the matrix. Initially, a typical Rac-induced
morphology dominates, with the cells displaying highly active
lamellipodia in all directions and punctate focal complexes.
Later on, RhoA activity causes the formation of stress fibers
and focal adhesions (Fig. 1A). Previous work from our
laboratory and other groups has shown that, when cells are
plated on FN, RhoA activity follows a biphasic pattern, where
significant activation of RhoA occurs after a transient
inhibition caused by Src-mediated p190 RhoGAP activation
(Arthur and Burridge, 2001; Arthur et al., 2000; Ren et al.,
1999). In this study, we used a modified experimental system
focused on the activation phase of RhoA on FN. NIH 3T3
fibroblasts were held in suspension for 2 hours, causing a very
efficient reduction in RhoA activity. Once plated on FN,
instead of the biphasic pattern described previously, a steady
increase in activity of RhoA is observed (Fig. 1B).
To identify the GEF(s) responsible for RhoA activation
downstream of FN, we performed pulldown assays with the
nucleotide-free RhoA mutant RhoA(17A). Previous work
from our laboratory has validated the use of RhoA(17A) in
affinity precipitations for activated GEFs. We have shown that
RhoA(17A) preferentially binds to GEFs, and not Rho
effectors or GAPs. Furthermore, this interaction is specific as
RhoA(17A) can only precipitate RhoA-specific GEFs, and not
Rac- or Cdc42-specific GEFs (Arthur et al., 2002; Garcia-
Mata et al., 2006; Noren et al., 2003). Initially, an unbiased
proteomics approach was employed. Suspended and FN-
adherent fibroblasts were lysed, and pulldowns performed
with purified RhoA(17A). Silver-stained samples were then
examined for protein bands whose association with
RhoA(17A) increased upon adhesion to FN (data not shown).
The most consistent and reproducible increase in interaction
with RhoA(17A) was observed for an approximately 110-kDa
band, which was identified by mass spectrometry as the
RhoA-specific GEF Lsc (also known as ‘Lbc’s second
cousin’). 
To confirm these data, identical experiments were
performed and samples blotted with an antibody against Lsc.
Specifically, mouse fibroblasts were serum starved for 3
hours, held in suspension for 2 hours in serum-free media and
plated onto FN-coated dishes for various periods of time. The
association between endogenous Lsc and RhoA(17A)
increased upon plating of cells on FN, indicative of an increase
in activity of the GEF (Fig. 1C). Thus far, activation of
Lsc/p115 RhoGEF by FN has been seen in all cell lines we
have tested, including REF52 and HeLa cells (data not
shown). We were also able to detect FN-induced activation of
the closely related GEF LARG (Fig. 1C). Unlike the related
RGS-GEFs Lsc and LARG, other RhoA GEFs such as Dbl or
Ect2 were not activated by attachment to FN (Fig. 1C). These
experiments therefore suggested that the activation of the
related RGS-GEFs Lsc/p115 RhoGEF and LARG by FN is a
specific process. Previous work with the RGS-GEFs has
focused on their established function downstream of GPCR
stimulation. These experiments demonstrate for the first time
the ability of FN to activate Lsc/p115 RhoGEF and LARG and
therefore suggest a novel role for these members of the RGS-
GEF family.
Lsc/p115 RhoGEF and LARG can increase formation of
stress fibers and partially colocalize with focal adhesions
on FN
As a first step to determine whether Lsc/p115 RhoGEF could
affect RhoA function downstream of adhesion to FN, we
overexpressed a construct containing GFP-tagged wild-type
p115 RhoGEF [GFP-p115(FL)] in REF52 fibroblasts (Fig.
2A). Interestingly, at early time points during spreading on FN,
compared with non-expressing cells, cells overexpressing
GFP-p115(FL) demonstrated an increased formation of
cortical actin bundles known as arcs (Fig. 2B, top panel,
arrow). Although not a commonly studied actin structure, arcs
have been shown to be dependent on RhoA activity and have
been described as precursors to stress fibers (Hotulainen and
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Lappalainen, 2006; Zhang et al., 2003). As expected, at later
time points, cells overexpressing GFP-p115(FL) demonstrated
an increase in formation of stress fibers when compared with
control cells (Fig. 2B). Identical results were obtained with
overexpression of a GFP-tagged LARG construct (Fig. 2B).
Over the time course of FN attachment, localization of GFP-
p115(FL) was observed to be mainly cytoplasmic, with
increased staining intensity visible in discrete ‘patches’
proximal to the periphery of the cells (Fig. 2B,C). Confocal
images taken at the ventral surface of the cells revealed that
these discrete patches of GFP-p115(FL) can partially
colocalize with focal adhesions, as visualized by
immunostaining for paxillin (Fig. 2C, arrows). Once again,
identical results were obtained with overexpression of a GFP-
tagged LARG construct (Fig. 2C). Therefore, these
overexpression experiments provided initial evidence that
Lsc/p115 RhoGEF and LARG can increase RhoA signaling
and partially colocalize to focal adhesions upon adhesion to
FN.
Knockdown of Lsc/p115 RhoGEF and LARG together
inhibits formation of stress fibers and RhoA activity
downstream of adhesion to FN
To evaluate the role of Lsc and LARG in the function of RhoA
downstream of FN, we knocked down expression of Lsc using
RNAi. REF52 fibroblasts were transiently transfected with
knockdown (KD) oligonucleotides against Lsc and LARG,
individually or together. At 48 to 72 hours post transfection,
the cells were serum starved, held in suspension and plated
onto FN-coated coverslips. No significant difference in
formation of stress fibers was observed when each GEF was
knocked down alone (data not shown). However, cells
transfected with both KD oligonucleotides against Lsc and
LARG demonstrated a significant decrease in formation of
stress fibers, as compared with cells transfected with a control
siRNA oligonucleotide (Fig. 3A, top panel). Furthermore,
while double-KD Lsc-LARG cells were able to form small
peripheral focal complexes, they were defective in the ability
to form Rho-induced focal adhesions (Fig. 3A, bottom panel).
Fig. 1. Adhesion to FN causes activation of RhoA and the RhoA-specific GEFs Lsc/p115 RhoGEF and LARG. Mouse fibroblasts were starved
in serum-free media and then held in suspension in the same media for 2 hours. (A) Cells were plated onto FN-coated coverslips for the times
indicated, then fixed and stained with phalloidin to visualize F-actin, and antibodies against phosphotyrosine to visualize focal adhesions. Bar,
40 m. (B,C) Cells were plated onto FN-coated dishes for the times indicated, lysed and (B) pulldowns performed with GST-RBD and samples
blotted with an antibody against RhoA, or (C) pulldowns performed with GST-RhoA(17A) and samples blotted with antibodies against the












The efficiency of knockdown of Lsc and LARG is
demonstrated in Fig. 3B. Expression of the RhoA GEF Lfc was
unaffected in these knockdown cells, demonstrating the
specificity of the siRNA (Fig. 3B).
When assayed for RhoA activity, double-KD Lsc-LARG
cells demonstrated a dramatic decrease in the ability to activate
RhoA by adhesion to FN compared with control cells (Fig. 3C).
The inability of the Lsc-LARG siRNA to inhibit RhoA
activation completely is probably due to incomplete knockdown
of the GEFs. Importantly, the defect in RhoA activation in
double-KD Lsc-LARG cells can be rescued by re-expression of
wild-type human p115 RhoGEF (Fig. 3D). These experiments
showed that the RGS-GEFs Lsc/p115 RhoGEF and LARG are
both involved in regulating RhoA downstream of FN. 
Formation of stress fibers and focal adhesions
downstream of adhesion to FN is inhibited by a DH-dead
mutant of Lsc/p115 RhoGEF
To explore further the role of Lsc/p115 RhoGEF in RhoA
activation by FN, and to determine whether the GEF activity
of the protein is necessary for this function, we decided to use
a mutant of p115 RhoGEF that lacks the ability to exchange
nucleotide on RhoA. To create a catalytically inactive form of
p115 RhoGEF [p115(4A)], we mutated four different residues
in the DH domain of p115 RhoGEF (Fig. 2A). These residues
are conserved in different RhoA GEFs and have been shown
to be important for GTPase binding and catalytic activity
(Kristelly et al., 2004; Rossman and Sondek, 2005; Worthylake
et al., 2000). As expected, p115(4A) showed significantly
decreased binding to RhoA(17A) compared with the wild-type
protein (Fig. 4A). We hypothesized that overexpression of the
p115(4A) construct would act in a dominant-negative fashion,
sequestering FN-induced signals away from the endogenous
GEFs involved in RhoA activation by FN (such as Lsc/p115
RhoGEF and LARG), thus causing a loss of signaling to RhoA
and a subsequent loss of formation of stress fibers and focal
adhesions.
To test this hypothesis, REF52 cells transfected with an N-
terminally GFP-tagged p115(4A) construct were plated onto
FN, and stress fibers and focal adhesions visualized by
immunofluorescence staining. Compared with control cells,
formation of stress fibers and focal adhesions was either
reduced or completely inhibited in cells overexpressing GFP-
p115(4A) (Fig. 4B). To exclude the possibility that the loss of
Journal of Cell Science 120 (22)
Fig. 2. Lsc/p115 RhoGEF and LARG increase
stress fibers and localizes to focal adhesions on
FN. (A) Domain structure of full-length p115
RhoGEF [p115(FL)] and the different mutants
used in this study. The DH-dead p115(4A)
mutant contains alanine point substitutions (*)
of four residues (E423, K567, L570, N603) in
the DH domain that are important for the
catalytic exchange reaction. The p115(N)
mutant lacks the N-terminus of the protein
containing the RGS domain. All constructs
were cloned into N-terminal GFP- or V5-
tagged vectors. (B,C) REF52 fibroblasts were
transfected with vector encoding either GFP-
p115(FL) or GFP-LARG(FL). 24 hours post
transfection, cells were serum-starved, held in
suspension for 2 hours and plated onto FN-
coated coverslips for the times indicated.
(B) The cells were then fixed and stained with
phalloidin to visualize F-actin. Arrows in the
top panels point to the tight cortical actin
bundles known as arcs. Arrows in the bottom
panels point to the discrete patches of p115
RhoGEF or LARG localization. Bar, 40 m.
(C) The cells were fixed and stained with
antibody against paxillin to visualize focal
adhesions. The images represent 0.3 m
confocal sections at the ventral surface of the
cells. Arrows point to areas of colocalization
between paxillin-containing focal adhesions
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stress fibers is a result of sequestration of RhoA by p115(4A)
caused by overexpression, cells transfected with vector
encoding p115(4A) were plated onto FN and treated briefly
with nocodazole. Depolymerization of microtubules by
nocodazole has been shown to activate RhoA through the
RhoA GEF Lfc (Krendel et al., 2002). As expected, nocodazole
treatment was able to rescue formation of stress fibers in
p115(4A)-overexpressing cells, suggesting that the loss of
stress fibers seen in cells overexpressing p115(4A) is not due
to sequestration of endogenous RhoA (Fig. 4C). Furthermore,
in agreement with the effect on formation of stress fibers and
focal adhesions, overexpression of p115(4A) was also able to
inhibit activation of RhoA by FN (Fig. 4D). These experiments
with a DH-dead mutant of Lsc/p115 RhoGEF further support
a role for Lsc/p115 RhoGEF in regulating RhoA signaling
downstream of adhesion to FN.
Activation of Lsc/p115 RhoGEF by FN involves integrin
receptors but not GPCRs
In addition to tandem DH-PH domains, the members of the
RGS-GEF family all contain an N-terminal RGS domain. The
RGS domain is so named because of its similarity to the RGS
box of the regulators of G-protein signaling (RGS) proteins. In
response to serum factors such as lysophosphatidic acid (LPA),
RGS-GEFs bind to activated G12/13 proteins through their
RGS domain and stimulate the intrinsic GTPase activity of the
G12/13 proteins. In turn, interaction with the RGS domain
allows G12/13 proteins to activate these GEFs (Rossman et al.,
2005).
As activation of Lsc/p115 RhoGEF and LARG by LPA is a
well-documented event, all of the experiments conducted in
this study were performed in the absence of serum to ensure
that the cells were not exposed to signals other than adhesion
to FN. Our experiments have therefore suggested that the
ability of FN to activate Lsc is independent of GPCR signaling.
However, to further exclude the possibility of GPCR
involvement in Lsc/p115 RhoGEF activation by FN, we made
use of a mutant of p115 RhoGEF that lacks the N-terminal
region of the protein containing the RGS domain [p115(N),
depicted in Fig. 2A]. It has been previously shown that, unlike
full-length protein, p115(N) is incapable of binding to
constitutively active G13 and will not translocate to the
Fig. 3. Knockdown of Lsc/p115 RhoGEF and LARG
decreases formation of stress fibers and focal
adhesions and RhoA activity downstream of FN.
(A) REF52 cells were transfected with either control
or siRNA oligonucleotides against Lsc and LARG as
described in Materials and Methods. 72 hours post
transfection, the cells were serum starved, held in
suspension for 2 hours and plated onto FN-coated
coverslips for 90 minutes. The cells were fixed and
stained with phalloidin and antibody against
phosphotyrosine to visualize stress fibers and focal
adhesions. Bar, 40 m. (B) Control cells or cells
transfected with siRNA against Lsc and LARG were
lysed and samples blotted with antibodies against
Lsc and LARG to demonstrate the efficiency of
knockdown. Identical blots with an antibody against
Lfc show that protein levels of the closely related
GEF Lfc are unaffected, demonstrating the
specificity of the knockdown. (C) Fibroblasts were
transfected with either control or siRNA
oligonucleotides against Lsc and LARG. 72 hours
post transfection, the cells were serum-starved, held
in suspension for 2 hours and plated onto FN-coated
dishes for 60 minutes. The cells were then lysed,
GST-RBD pulldowns performed and samples blotted
with an antibody against RhoA to visualize the levels
of RhoA activity. (D) Fibroblasts were transfected
with siRNA oligonucleotides against Lsc and LARG.
48 hours post transfection, the cells were re-
transfected with either a vector control or a V5-
tagged full-length p115 RhoGEF construct. 72 hours
post transfection, the cells were processed for Rho
activity assays, as described in (C) above. Lysates
were also blotted with an antibody against V5 to












membrane when these proteins are coexpressed, suggesting
that p115(N) cannot be activated by LPA (Bhattacharyya and
Wedegaertner, 2003a; Bhattacharyya and Wedegaertner,
2003b). To confirm these data in our experimental system,
mouse fibroblasts were transfected with vector encoding either
V5-tagged full-length p115 RhoGEF [p115(FL)] or RGS-
deleted p115 RhoGEF [p115(N)]. At 24 hours post
transfection, the cells were serum starved for 16 hours, treated
with 5% serum and GEF activity assayed by RhoA(17A)
pulldowns. Fig. 5A demonstrates that, unlike p115(FL),
p115(N) was not significantly activated by serum treatment.
Next, cells overexpressing p115(N) were serum starved,
plated onto FN, and RhoA(17A) assays performed.
Importantly, unlike serum treatment, adhesion to FN was able
to stimulate activation of p115(N) (Fig. 5B). In addition,
overexpression of p115(N) in double-KD Lsc-LARG cells
was able to rescue the defect in RhoA activation when the cells
are plated onto FN (Fig. 5C). Therefore, both these
Journal of Cell Science 120 (22)
Fig. 4. DH-dead p115 RhoGEF inhibits formation of stress fibers and focal adhesions and RhoA activity on FN. (A) REF52 fibroblasts were
transfected with vector encoding GFP-p115(FL) or GFP-p115(4A). 24 hours post transfection, the cells were lysed, pulldowns performed with
RhoA(17A) and samples blotted with an antibody against GFP. (B) REF52 cells transfected with vector encoding GFP-p115(4A) were serum-
starved, held in suspension for 2 hours and plated onto FN-coated coverslips. The cells were then fixed and stained with phalloidin to visualize
F-actin and an antibody against phosphotyrosine to visualize focal adhesions. Bar, 40 m. (C) REF52 cells overexpressing p115(4A) were
plated onto FN-coated coverslips for 60 minutes. The cells were then treated with either DMSO or 10 M nocodazole for 30 minutes and fixed
and stained with phalloidin to visualize stress fibers. Cells were scored according to whether they had prominent stress fibers versus few to no
stress fibers. (D) Cells were transfected with GFP-p115(4A), serum-starved and held in suspension for 2 hours. The cells were then plated onto
FN-coated dishes, and GST-RBD pulldowns performed, and samples blotted with an antibody against RhoA to visualize the levels of RhoA
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experiments suggest that activation of Lsc/p115 RhoGEF by
FN is independent of GPCR signaling. 
To resolve further the mechanism of Lsc/p115 RhoGEF
activation by FN, we decided to investigate whether integrins
and/or syndecans were involved. To do this, we plated serum-
starved mouse fibroblasts onto either full-length FN, the CBD
fragment of FN alone or full-length FN treated with heparin
(to block syndecan adhesion). Compared with suspended cells,
activation of Lsc was observed upon adhesion in all cases,
indicating that integrin adhesion alone is sufficient for
activation of Lsc (Fig. 5D). The experiments above
demonstrate that activation of the RhoA GEF Lsc/p115
RhoGEF by adhesion to FN occurs through a mechanism that
involves integrins but is independent of GPCRs.
Discussion
Adhesion to the ECM has long been known to influence many
characteristics of cells, including their growth, survival,
morphology and migratory properties. With the discovery that
members of the Rho family of GTPases regulate the
organization of the cytoskeleton (Ridley and Hall, 1992; Ridley
et al., 1992), it was logical to ask whether the effects of the
ECM on morphology and migration of cells are mediated by
Rho proteins. Using the experimental model of plating
suspended cells (typically fibroblasts) on surfaces coated with
ECM proteins such as FN, rapid activation of Rac1 and Cdc42
was demonstrated (Price et al., 1998). Adhesion to FN was
shown to induce a biphasic RhoA activity pattern, where a
transient dip in activity was followed by a sustained rise in
activity (Ren et al., 1999). Our laboratory has been interested
in the signaling events that regulate the different stages of Rho
activity in response to adhesion to FN. In previous work, we
demonstrated that integrin engagement stimulated activation of
Src kinase activity, leading to the phosphorylation and
activation of p190RhoGAP, and a transient decrease in Rho
GTP levels (Arthur et al., 2000). In the present study, we
wanted to identify the specific GEF(s) responsible for the
activation phase of RhoA in response to adhesion to FN.
Several previous studies have investigated the role of
specific RhoA GEFs in different adhesion signaling
pathways. For example, it was demonstrated that p190
RhoGEF is phosphorylated by focal adhesion kinase (FAK)
in response to laminin engagement in neuronal cells (Zhai et
al., 2003). Also, involvement of Lsc in a FN adhesion
Fig. 5. Activation of Lsc/p115 RhoGEF by
adhesion to FN involves integrins but is
independent of GPCRs. (A) Fibroblasts were
transfected with constructs expressing either
V5-p115(FL) or V5-p115(N). 24 hours post
transfection, the cells were serum starved for
16 hours, treated with 5% fetal bovine serum
for the times indicated and pulldowns
performed with RhoA(17A). (B) V5-
p115(N)-transfected fibroblasts were serum
starved, held in suspension for 2 hours, plan
ted onto FN-coated dishes and RhoA(17A)
pulldowns performed. (C) Fibroblasts were
transfected with siRNA oligonucleotides
against Lsc and LARG. 48 hours post
transfection, the cells were re-transfected with
either a vector control or V5-p115(N). The
next day, all the cells were serum starved, held
in suspension for 2 hours and plated onto FN-
coated dishes for 60 minutes. The cells were
then lysed, GST-RBD pulldowns performed
and samples blotted with an antibody against
RhoA to visualize the levels of RhoA activity.
Lysates were also blotted with an antibody
against V5 to show the levels of expression of
V5-p115(N). (D) Fibroblasts were serum
starved and held in suspension for 2 hours. To
prevent the production and secretion of
endogenous FN by the fibroblasts, 25 g/ml
cycloheximide was included in the media
during starvation and suspension. The cells
were then plated onto dishes coated with FN,
CBD or FN plus heparin. Samples were lysed,
incubated with RhoA(17A) and processed for













pathway was implied by work in Lsc-knockout neutrophils,
which demonstrate a reduction in the ability to bind to FN
when stimulated with formyl-peptide (fMLP) (Francis et al.,
2006). In the current study, we took an unbiased proteomics
approach to identify the specific RhoA GEF(s) responsible
for regulating RhoA signaling in response to adhesion to FN.
Initially, Lsc/p115 RhoGEF was identified as a GEF whose
activity [as assessed by RhoA(17A) binding] was stimulated
upon adhesion to FN. Further investigation using western
blots demonstrated that, although the related RGS-GEF
LARG is also activated upon adhesion of fibroblasts to FN,
other GEFs such as Ect2 or Dbl are not (Fig. 1). We have
established that both Lsc/p115 RhoGEF and LARG are
responsible for the ability of cells to activate RhoA
downstream of FN, as knockdown of both these GEFs in
fibroblasts greatly diminishes FN-induced RhoA activation as
well as formation of stress fibers and focal adhesions (Fig.
3). The residual RhoA activity present in the double-KD Lsc-
LARG fibroblasts is probably due to incomplete knockdown
of these GEFs. Although we cannot rule out the possibility
that other GEFs play a secondary role in this pathway (such
as the third RGS-GEF family member, PDZ RhoGEF),
considering the drastic effect of double KD of Lsc and LARG
on FN-induced RhoA signaling in fibroblasts, the
contributions of other GEFs, if any, are probably minor.
Considering the well-described function of the RGS-GEF
family in mediating LPA-induced RhoA activity, we were
initially surprised to have identified Lsc/p115 RhoGEF and
LARG as being involved in FN-induced RhoA activity as well.
Consistent with a role for these GEFs in RhoA signaling
downstream of matrix adhesion, Lsc/p115 RhoGEF and LARG
are present in discrete patches at the periphery of the cell that
colocalize with paxillin-containing focal adhesions (Fig. 2C).
Furthermore, experiments using an RGS-deleted mutant of
p115 RhoGEF confirmed that activation of Lsc/p115 RhoGEF
by FN is unrelated to the GPCR pathway (Fig. 5). Several lines
of evidence have indicated that RGS-GEFs can function in
diverse signaling pathways unrelated to GPCR signaling.
LARG has been shown to bind to the insulin-like growth factor
1 (IGF-1) receptor and potentially is responsible for
transducing signals from IGF-1 to RhoA (Taya et al., 2001).
Plexin-B1, a member of a family of receptors that mediate
axonal guidance by responding to repulsive cues, has also been
shown to bind to PDZ-RhoGEF and LARG and to signal to
RhoA through them (Swiercz et al., 2002). Interestingly,
previous studies have shown that CD44, a receptor for the
ECM component hyaluronan, can bind to both Lsc/p115
RhoGEF and LARG, and this interaction increases RhoA
signaling (Bourguignon et al., 2003; Bourguignon et al., 2006).
The specific roles of integrins and syndecans in the
downstream activation of RhoA are a matter of controversy in
the field. Saoncella and colleagues determined that, although
stress fibers and focal adhesions will not form on cells plated
onto the cell binding domain (CBD) of FN alone, they will
form upon addition of an antibody against syndecan-4, which
suggests that syndecan-4 is required for the activation of RhoA
(Saoncella et al., 1999). However, a recent paper demonstrated
that CBD is sufficient for formation of stress fibers and focal
adhesions, suggesting that integrins alone can induce RhoA
activity (Wang et al., 2005). Furthermore, it was shown that,
although the heparin-binding domain (HBD) alone cannot
induce stress fibers and focal adhesions, it can contribute to the
formation of these structures when the CBD is present at
suboptimal concentrations (Wang et al., 2005). Therefore,
having determined that the GEFs Lsc/p115 RhoGEF and
LARG are activated by adhesion to FN, we wanted to
investigate which adhesion receptors were involved in this
process. Our results show that Lsc can be activated by the
plating of cells on CBD alone or on heparin-treated FN (which
blocks syndecan-4 binding to HBD), which suggests that
integrins are sufficient for the activation of the GEF in our
experimental system (Fig. 5D).
Previous studies on RGS-GEFs have explored the
mechanisms by which these GEFs are activated. Specifically,
it has been shown that all the RGS-GEFs can dimerize through
a C-terminal homo-oligomerization domain, and that
dimerization inhibits the GEF activity of the proteins (Chikumi
et al., 2004). It has also been shown that RGS-GEFs are
substrates for several different kinases. Although the effects of
phosphorylation on RGS-GEFs have not been determined,
there is some evidence to suggest that phosphorylation causes
an increase in their exchange activity. Protein kinase C 
(PKC) can be activated by adhesion to FN (Disatnik et al.,
2002; Dovas et al., 2006) and has been shown to phosphorylate
p115 RhoGEF in response to thrombin treatment (Holinstat et
al., 2003). Furthermore, LARG is phosphorylated by both FAK
and Tec kinase (Chikumi et al., 2002; Suzuki et al., 2003). The
exact processes through which Lsc/p115 RhoGEF and LARG
are activated by adhesion to FN, whether by phosphorylation
or some other mechanism, remain to be explored in detail.
Materials and Methods
Cell lines, reagents and constructs
NIH 3T3 and REF52 fibroblasts were grown in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen) supplemented with 10% bovine calf serum or fetal
bovine serum (Sigma), respectively, and antibiotic-antimycotic solution (Sigma).
Nocodazole was purchased from Calbiochem, and cycloheximide was purchased
from Sigma. A construct expressing full-length p115 RhoGEF (residues 1-913,
corresponding to IMAGE clone #3451036) was obtained from Invitrogen. A
construct expressing full-length LARG was obtained from Alexander Belyavsky
(Engelhardt Institute of Molecular Biology, Russia). The DH-dead mutant (with
residues E423, K567, L570 and N603 mutated to alanine) of p115 RhoGEF was
made using the QuikChange Mutagenesis Kit according to the manufacturer’s
instructions (Stratagene). The mutant of p115 RhoGEF lacking the RGS-domain-
containing N-terminus (residues 1-252 deleted) was amplified by PCR using the
appropriate primers. All full-length and mutant DNA fragments mentioned above
were cloned into GFP and V5 N-terminally tagged vectors using Gateway
Technology (Invitrogen), according to the manufacturer’s instructions. Accuracy of
all constructs was verified by DNA sequencing.
Purification of recombinant proteins
FN was purified from blood plasma as described previously (Engvall and Ruoslahti,
1977) or obtained from Invitrogen. A construct containing the cell-binding domain
(CBD) of FN (containing FN repeats III7-10) in a His-tagged pET 15b vector was
obtained from Ikramuddin Aukhil (UNC Chapel Hill). Expression and purification
of CBD was performed as described previously (Aukhil et al., 1993; Hashimoto-
Uoshima et al., 1997). Construction of the pGEX4T-1 prokaryotic expression
constructs containing RhoA(G17A) and the Rho-binding domain (RBD) of
Rhotekin have been described previously (Liu and Burridge, 2000; Reuther et al.,
2001). Briefly, expression of the fusion proteins in Escherichia coli was induced
with 100 M IPTG for 12-16 hours at room temperature. Bacterial cells were lysed
in buffer containing 50 mM Tris pH 7.6 (for GST-RBD) or 20 mM HEPES pH 7.6
[for GST-RhoA(17A)], 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 10 g/ml each
of aprotinin and leupeptin, and 1 mM phenylmethylsulfonyl fluoride, and the
proteins purified by incubation with glutathione-sepharose 4B beads (GE
Healthcare) at 4°C.
FN plating
Petri dishes or coverslips were coated overnight at 4°C with a 30 g/ml solution of
FN in phosphate-buffered saline (PBS; Invitrogen), or with a 12.5 g/ml solution
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of CBD in PBS (Fig. 5D). The next morning, the plates were washed with PBS,
and blocked for 1 hour at 37°C in a solution of DMEM supplemented with 0.5%
delipidated bovine serum albumin (BSA; Sigma). As indicated in Fig. 5D, 100
g/ml heparin (Sigma) was added to a subset of FN-coated dishes during the
delipidated BSA incubation. Before all experiments conducted in this study,
fibroblasts were completely deprived of serum by extensive washing with PBS,
followed by incubation for 3-16 hours in 0.5% delipidated BSA-DMEM. The cells
were then held in suspension for 2 hours in the same media, plated onto FN-coated
dishes or coverslips for various times and processed for pulldown experiments or
immunofluorescence, respectively.
RBD and nucleotide-free (NF) RhoA pulldowns
Active RhoA pulldown experiments were performed as described elsewhere (Arthur
and Burridge, 2001). Briefly, suspended and adherent fibroblasts were lysed in 50
mM Tris (pH 7.6), 500 mM NaCl, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholate,
10 mM MgCl2, 200 M orthovanadate and protease inhibitors. Lysates were
clarified by centrifugation, equalized for total volume and protein concentration,
and rotated for 30 minutes with 30 g of purified GST-RBD bound to glutathione-
sepharose beads. The bead pellets were washed in 50 mM Tris (pH 7.6), 150 mM
NaCl, 1% Triton X-100, 10 mM MgCl2, 200 M orthovanadate, with protease
inhibitors, and subsequently processed for SDS-PAGE. Affinity precipitation of
exchange factors with the nucleotide-free RhoA mutant (G17A) has been described
in detail in previous work from our laboratory (Arthur et al., 2002; Garcia-Mata et
al., 2006; Noren et al., 2003). Briefly, cells were lysed in 20 mM HEPES (pH 7.6),
150 mM NaCl, 1% Triton X-100, 5 mM MgCl2, 200 M orthovanadate plus
protease inhibitors. Equalized and clarified lysates were incubated with 20 g of
purified RhoA(17A) bound to glutathione-sepharose beads for 60 minutes at 4°C.
Samples were then washed in lysis buffer and processed for SDS-PAGE. For the
mass spectrometric analysis, the gel was stained with Coomassie Blue, bands of
interest analyzed by MALDI-TOF-MS, and selected tryptic peptides were
sequenced by nano-ESI-MS/MS at the UNC Proteomics Facility.
Transfections and immunofluorescence
Transfection of NIH 3T3 and REF52 cell lines was performed using Lipofectamine
and Plus Reagent, according to the manufacturer’s instructions (Invitrogen). For
immunofluorescence, coverslips were fixed for 15 minutes in 3.7% formaldehyde
(Sigma) and permeabilized for 10 minutes in 0.2% Triton X-100 (Sigma). Primary and
secondary antibody incubations were performed for 1 hour at room temperature. Anti-
Paxillin was from BD Biosciences, and anti-phosphotyrosine (PY99) was from Santa
Cruz Biotechnology. Alexa Fluor 594 phalloidin and goat anti-mouse Alexa Fluor 488
and 594 were obtained from Molecular Probes. Immunofluorescence images were
taken with a Zeiss axiovert 200M microscope equipped with a Hamamatsu ORCA-
ERAG digital camera and Metamorph Workstation (Universal Imaging Corp.).
Confocal images were taken with a Zeiss 510 Meta laser scanning confocal microscope
located in the Michael Hooker Microscopy Facility at UNC-Chapel Hill.
Western blotting
Cell lysates subjected to SDS-PAGE were transferred to polyvinylidene fluoride
(PVDF) membranes (Millipore). For western blotting, membranes were incubated
with primary and secondary antibodies for 1 hour at room temperature. Blots were
developed with SuperSignal West Pico Chemiluminescent Substrate (Pierce) and
visualized using Kodak BioMax film (Kodak). For quantification of western blots,
intensity values of bands were measured from three different repeats for each
experiment using Image J software (NIH). The graphs for all experiments are plotted
as the fold increase over the suspension sample, and the error bars represent the
standard error of the mean (s.e.m.). RhoA and Lsc antibodies were purchased from
Santa Cruz Biotechnology. Anti-V5 was obtained from Invitrogen, and anti-GFP
was from Roche. The antibodies against LARG and Lfc were kind gifts of Kozo
Kaibuchi (Nagoya University, Japan) and Robert Rottapel (Ontario Cancer Institute,
Canada), respectively. Peroxidase-conjugated goat anti-mouse and bovine anti-goat
antibodies were from Jackson ImmunoResearch Laboratories.
siRNA oligonucleotides
Control siGLO oligonucleotides and those specific for knockdown of mouse Lsc
(targeted sequence: 5-GGGCTGAGCAGTATCCTAG-3) and LARG (targeted
sequence: 5-GGACGGAGCTGTAATTGCA-3) were purchased from Dharmacon.
The Lsc oligonucleotide used displayed 100% homology to both mouse and rat Lsc
nucleotide sequence, and thus was able to knockdown Lsc protein levels in both NIH
3T3 and REF52 fibroblasts. The Lsc oligonucleotide did display base-pair mismatches
to the human p115 RhoGEF nucleotide sequence and thus did not inhibit the re-
expression of human p115 RhoGEF in the knockdown fibroblasts. Transfection of
oligonucleotides was performed with the TransIT-siQUEST reagent, obtained from
Mirus Corporation, according to the manufacturer’s instructions. Efficiency and
specificity of knockdown for each experiment was assayed by western blot.
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